Helminths and immunological tolerance

Transplantation

Volumn 97, Issue 2, 2014, Pages 127-132

  Johnston, Chris J C ^a,b   McSorley, Henry J ^a   Anderton, Stephen M ^b   Wigmore, Stephen J ^b   Maizels, Rick M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Allograft rejection; Allograft tolerance; Helminth

Indexed keywords

ANIMALS; ECHINOCOCCOSIS; HELMINTHIASIS; HUMANS; IMMUNE TOLERANCE; NIPPOSTRONGYLUS; SCHISTOSOMIASIS; STRONGYLIDA INFECTIONS; TRANSPLANTATION IMMUNOLOGY; TRICHINELLOSIS;

EID: 84895128486     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182a53f59     Document Type: Review

References (54)

1. Halloran PF. Immunosuppressive drugs for kidney transplantation. N Engl J Med 2004; 351: 2715.
2. Eltzschig HK, Eckle T. Ischemia and reperfusionVfrom mechanism to translation. Nat Med 2011; 17: 1391.
3. Neuberger J. Rationing life-saving resourcesVhow should allocation policies be assessed in solid organ transplantation. Transpl Int 2011; 25: 3.
4. Meier-Kriesche H-U, Schold JD, Srinivas TR, et al. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004; 4: 378.
5. Lamb KE, Lodhi S, Meier-Kriesche HU. Long-term renal allograft survival in the United States: A critical reappraisal. Am J Transplant 2010; 11: 450.
6. Lodhi SA, Lamb KE, Meier-Kriesche HU. Solid organ allograft survival improvement in the United States: The long-term does not mirror the dramatic short-term success. Am J Transplant 2011; 11: 1226.
7. Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med 2007; 357: 2601.
8. Opelz G, Dohler B. Lymphomas after solid organ transplantation: A collaborative transplant study report. Am J Transplant 2004; 4: 222.
9. Bluestone JA. Mechanisms of tolerance. Immunol Rev 2011; 241: 5.
10. Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature 1953; 172: 603.
11. Wood KJ, Bushell A, Hester J. Regulatory immune cells in transplantation. Nat Rev Immunol 2012; 12: 417.
12. Kawai T, Cosimi AB, Spitzer TR, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008; 358: 353.
13. Scandling JD, Busque S, Dejbakhsh-Jones S, et al. Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants. Am J Transplant 2012; 12: 1133.
14. Waldmann H, Graca L, Cobbold S, et al. Regulatory T cells and organ transplantation. Semin Immunol 2004; 16: 1.
15. Trzonkowski P, Bieniaszewska M, Juvcicska J, et al. First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127- T regulatory cells. Clin Immunol 2009; 133: 22.
16. Edinger M, Hoffmann P. Regulatory T cells in stem cell transplantation: Strategies and first clinical experiences. Curr Opin Immunol 2011; 23: 679.
17. Leslie M. Immunology. Regulatory T cells get their chance to shine. Science 2011; 332: 1020.
18. McMurchy AN, Bushell A, Levings MK, et al. Moving to tolerance: Clinical application of T regulatory cells. Semin Immunol 2011; 23: 314.
19. Bushell A, Jones E, Gallimore A, et al. The generation of CD25+CD4+ regulatory T cells that prevent allograft rejection does not compromise immunity to a viral pathogen. J Immunol 2005; 174: 3290.
20. Weinstock JV, Summers R, Elliott DE. Helminths and harmony. Gut 2004; 53: 7.
21. Maizels RM, Yazdanbakhsh M. Immune regulation by helminth parasites: Cellular andmolecular mechanisms.Nat Rev Immunol 2003; 3: 733.
22. Mcsorley HJ, Maizels RM. Helminth infections and host immune regulation. Clin Microbiol Rev 2012; 25: 585.
23. Correale J, Farez MF. The impact of parasite infections on the course of multiple sclerosis. J Neuroimmunol 2011; 233: 6.
24. Summers RW. Trichuris suis therapy in Crohns disease. Gut 2005; 54: 87.
25. Weinstock JV, Elliott DE. Translatability of helminth therapy in inflammatory bowel diseases. Int J Parasitol 2012; 43: 245.
26. Xia D, Yan LN, Li B, et al. Orthotopic liver transplantation for incurable alveolar echinococcosis: Report of five cases from West China. Transplant Proc 2005; 37: 2181.
27. Bresson-Hadni S, Blagosklonov O, Knapp J, et al. Should possible recurrence of disease contraindicate liver transplantation in patients with end-stage alveolar echinococcosis A 20-year follow-up study. Liver Transpl 2011; 17: 855.
28. Bresson-Hadni S, Koch S, Beurton I, et al. Primary disease recurrence after liver transplantation for alveolar echinococcosis: Long-term evaluation in 15 patients. Hepatology 1999; 30: 857.
29. Sailer M, Soelder B, Allerberger F, et al. Alveolar echinococcosis of the liver in a six-year-old girl with acquired immunodeficiency syndrome. J Pediatr 1997; 130: 320.
30. WHO Informal Working Group on Echinococcosis. Guidelines for treatment of cystic and alveolar echinococcosis in humans. Bull World Health Organ 1996; 74: 231.
31. Li T, Zhao J-M, Zhang Y, et al. Suppression of acute rejective response following orthotopic liver transplantation in experimental rats infected with Echinococcus multilocularis. Chin Med J 2011; 124: 2818.
32. Hepiretihan M, Erken A, Zhao J, et al. Immune responses on allograft heart transplantation in inbred rats infected with Echinococcosis multilocularis. Chin Med J 2012; 125: 4412.
33. Ledingham DL, McAlister VC, Ehigiator HN, et al. Prolongation of rat kidney allograft survival by nematodes. Transplantation 1996; 61: 184.
34. Liwski R, Zhou J, McAlister V, et al. Prolongation of allograft survival by Nippostrongylus brasiliensis is associated with decreased allospecific cytotoxic T lymphocyte activity and development of T cytotoxic cell type 2 cells. Transplantation 2000; 69: 1912.
35. Liu Z, Liu Q, Pesce J, et al. Nippostrongylus brasiliensis can induce B7- independent antigen-specific development of IL-4-producing T cells from naive CD4 T cells in vivo. J Immunol 2002; 169: 6959.
36. Pierson RN. Tolerance in heart transplantation: The Holy Grail, or an attainable goal Heart Fail Clin 2007; 3: 17.
37. Vincenzi R, Neto JS, Fonseca EA, et al. Schistosoma mansoni infection in the liver graft: The impact on donor and recipient outcomes after transplantation. Liver Transpl 2011; 17: 1299.
38. Kayler LK, Rudich SM, Merion RM. Orthotopic liver transplantation from a donor with a history of schistosomiasis. Transplant Proc 2003; 35: 2974.
39. Andraus W, Pugliese V, Pecora R, et al. Intentional use of Schistosoma mansoni-infected grafts in living donor liver transplantation. Liver Transpl 2012; 18: 867.
40. Mahmoud KM, Sobh MA, El-Agroudy AE, et al. Impact of schistosomiasis on patient and graft outcome after renal transplantation: 10 years follow-up. Nephrol Dial Transplant 2001; 16: 2214.
41. Aboul-Enein A, Butt K, Abboud A, et al. Prolonged skin allograft survival in chronic schistosomiasis. Surgery 1982; 91: 425.
42. Araujo FG, Coelho PM, Pereira LH, et al. Schistosoma mansoni: Impairment of the cell-mediated immune response in mice. Clin Exp Immunol 1977; 28: 289.
43. Svet-Moldavsky GJ, Shaghijan GS, Mkheidze DM, et al. Mouse transplantation immunity depressed by Trichinella spiralis. Lancet 1969; 2: 320.
44. Faubert GM, Tanner CE. Leucoagglutination and cytotoxicity of the serum of infected mice and of extracts of Trichinella spiralis larvae and the capacity of infected mouse sera to prolong skin allografts. Immunology 1975; 28: 1041.
45. Chimyshkyan KL, Shvkvatsabaya IK, Ovumyan HS, et al. The effect of Trichinella spiralis on graft-versus-host reaction, transplantation immunity and antibody formation. Biomedicine 1976; 25: 176.
46. Alkarmi T, Ijaz MK, Dar FK, et al. Suppression of transplant immunity in experimental trichinellosis. Comp Immunol Microbiol Infect Dis 1995; 18: 171.
47. Maizels RM, Balic A, Gomez-Escobar N, et al. Helminth parasitesV masters of regulation. Immunol Rev 2004; 201: 89.
48. Maizels RM, Hewitson JP, Murray J, et al. Immune modulation and modulators in Heligmosomoides polygyrus infection. Exp Parasitol 2012; 132: 76.
49. Zaccone P, Burton O, Miller N, et al. Schistosoma mansoni egg antigens induce Treg that participate in diabetes prevention in NOD mice. Eur J Immunol 2009; 39: 1098.
50. Webster KE, Walters S, Kohler RE, et al. In vivo expansion of Treg cells with IL-2-mAb complexes: Induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression. J Exp Med 2009; 206: 751.
51. Vokaer B, Charbonnier LM, Lematre PH, et al. Impact of interleukin- 2Yexpanded regulatory T cells in various allogeneic combinations on mouse skin graft survival. Transplant Proc 2012; 44: 2840.
52. Chen L, Wang T, Zhou P, et al. TLR engagement prevents transplantation tolerance. Am J Transplant 2006; 6: 2282.
53. Bager P, Kapel C, Roepstorff A, et al. Symptoms after ingestion of pig whipworm Trichuris suis eggs in a randomized placebo-controlled double-blind clinical trial. PLoS One 2011; 6: E22346.
54. McKay DM. The therapeutic helminth Trends Parasitol 2009; 25: 109.